Want to join the conversation?
$DOV 1Q15 PR: Full-year revenue is expected to decline 8-9%. Within this revenue forecast, organic growth is anticipated to decline 7-8%, completed acquisitions will provide approximately 3% growth, and FX is expected to be a 4% headwind. Full-year adjusted EPS is expected to be $3.75-3.90, including $0.16-0.19 of restructuring charges.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?